Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study - 10/05/21
Doi : 10.1016/j.jaad.2021.04.055
Yi Ji, MD, PhD a, ⁎ 
, Kaiying Yang, MD a, Jiangyuan Zhou, MD a, Xuepeng Zhang, MD a, Bo Xiang, MD, PhD a, Xian Jiang, MD, PhD b, Xuewen Xu, MD, PhD c, Tong Qiu, MD a, Shiyi Dai, MD a, Feiteng Kong, MD d, Guoyan Lu, MD e, Qingxia Qiu, MD f, Yongbo Zhang, MD g, Siyuan Chen, MD, PhD h, ⁎
, Kaiying Yang, MD a, Jiangyuan Zhou, MD a, Xuepeng Zhang, MD a, Bo Xiang, MD, PhD a, Xian Jiang, MD, PhD b, Xuewen Xu, MD, PhD c, Tong Qiu, MD a, Shiyi Dai, MD a, Feiteng Kong, MD d, Guoyan Lu, MD e, Qingxia Qiu, MD f, Yongbo Zhang, MD g, Siyuan Chen, MD, PhD h, ⁎ a Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China
b Department of Dermatology, West China Hospital of Sichuan University, Chengdu, China
c Department of Burn and Plastic Surgery, West China Hospital of Sichuan University, Chengdu, China
d Department of Pediatric Surgery, Sichuan Women and Children's Hospital, Chengdu, China
e Department of Pediatrics, West China Second University Hospital, Sichuan University Chengdu, Chengdu, China
f Department of Pediatric Surgery, Chengdu Shangjin Nanfu Hospital, Chengdu, China
g Department of Pediatric Surgery, Chengdu Women and Children's Central Hospital, Chengdu, China
h Pediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China
∗Reprint requests: Yi Ji, MD, PhD, Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, 37# Guo-Xue-Xiang, Chengdu 610041, ChinaDivision of OncologyDepartment of Pediatric SurgeryWest China Hospital of Sichuan University37# Guo-Xue-XiangChengdu610041China∗Correspondence to: Siyuan Chen, MD, PhD, Pediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, 37# Guo-Xue-Xiang, Chengdu 610041, ChinaPediatric Intensive Care UnitDepartment of Critical Care MedicineWest China Hospital of Sichuan University37# Guo-Xue-XiangChengdu610041China
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Monday 10 May 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| Drs Ji and Yang contributed equally to this article. |
|
| Funding sources: This work was supported by the National Natural Science Foundation of China (grant numbers: 81400862 and 81401606), the Key Project in the Science & Technology Program of Sichuan Province (grant number: 2019YFS0322), the Science Foundation for The Excellent Youth Scholars of Sichuan University (grant number: 2015SU04A15), and the 1·3·5 Project for Disciplines of Excellence–Clinical Research Incubation Project, West China Hospital of Sichuan University (grant numbers: 2019HXFH056 and 2020HXFH048). |
|
| IRB approval status: The study protocol was approved by the ethics committee on medical research of each participating site. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?